Seragon Pharmaceuticals develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer. read more

EMPLOYEE PARTICIPANTS: 4

TOTAL RATINGS: 106

CEO: Richard Heyman

Seragon Pharmaceuticals Director of Investor Relations Salaries in Baltimore, MD

$40k

$85k

$130k

$150k

$214k

$279k

N/A

Average Compensation

Director of Investor Relations Salaries at Seragon Pharmaceuticals

* estimated salary

Compensation at Seragon Pharmaceuticals by Department

In Baltimore, MD, The Communications Department averages $8,281 more than the Enterprise Risk Department.

Communications

$195,641 Avg. total comp.

Enterprise Risk

$187,360 Avg. total comp.

-$8k

Product

$176,398 Avg. total comp.

-$19k

How Directors of Investor Relations at Seragon Pharmaceuticals Rate Their Compensation

The majority of Directors of Investor Relations at Seragon Pharmaceuticals believe they're compensated fairly. 50% of Directors of Investor Relations at Seragon Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Seragon Pharmaceuticals

Do you believe you're paid fairly?

67% Yes

Does your company give annual bonuses?

50% Yes

Are you satisfied with your Benefits?

67% Yes

Director of Investor Relations Salaries at Similar Size Companies in Baltimore, MD

Rate your company